Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Urology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Right Lateral Digital Rectal Examination in Men with Suspected Prostate Disease
12
Mins
September 2024
The worldwide prevalence of benign prostatic hyperplasia (BPH) varies between 20–60% in men over 50 years. Similarly, about 50% of men…
Read more
20th January 2015
Kidney Stones and Ceftriaxone
Metabolic causes such as hypercalciuria, urinary tract infection, and obstruction are the most common aetiologies of urolithiasis, and drugs, although…
20th January 2015
How I Treat: Prostate Cancer With Minimally Invasive Techniques
Currently, 17-35% of newly diagnosed cases of prostate cancer (PrC) are classified as high-risk. This group of patients has the highest rate of…
28th November 2014
Infecciones urinarias recurrentes: resistencia a los antibióticos y directrices
La aparición y propagación de la resistencia a los antibióticos (RAB) es un factor crítico en la salud general y el bienestar. Debido a su prevalencia…
28th November 2014
Introducción a la carga que supone la cystitis recurrente y la justificación de la prevención
Esta cumbre, de carácter educativo y financiada por una beca independiente de OM/Vifor Pharma, ha reunido a expertos en urología y ginecología procedentes…
28th November 2014
Infecciones urinarias en grupos de población específicos y polémica en torno al tratamiento de la enfermedad
Resumen de las presentaciones seleccionadas de la cumbre OM Pharma/ViforPharma URO-VAXOM® celebrada en Buenos Aires (Argentina) los días 26 y 27 de abril de 2014
28th November 2014
Introduction to the Burden of Recurrent Cystitis and Rationale for Prevention
This educational summit, supported by an independent grant from OM/Vifor Pharma, brought together experts in the field of urology and gynaecology…
28th November 2014
Recurrent Urinary Tract Infections: Can Immunoactive Prophylaxis Improve Disease Management In Healthy Women?
This educational summit, supported by an independent grant from OM/Vifor Pharma, brought together experts in the field of urology and gynaecology from…
28th November 2014
Urinary Tract Infection in Specific Populations and Controversies in Disease Management
The physiological and anatomical changes associated with pathological and non-pathological conditions, such as pregnancy, can modify both the risk…
Loading posts...
« Previous
1
…
16
17
18
19
20
…
23
Next »